| ［1］ |
Mauppin C, Osio A, de Masson A, et al. Eczema/prurigo as an unusual presentation of Kimura′s disease［J］. Ann Dermatol Venereol, 2021,148（1）:49⁃50. doi: 10.1016/j.annder.2020.08. 047.
|
| ［2］ |
Sun QF, Xu DZ, Pan SH, et al. Kimura disease: review of the literature［J］. Intern Med J, 2008,38（8）:668⁃672. doi: 10.1111/j.1445⁃5994.2008.01711.x.
|
| ［3］ |
Kinoshita M, Ogawa Y, Onaka M, et al. Mepolizumab⁃responsive Kimura disease［J］. J Allergy Clin Immunol Pract, 2021,9（7）:2928⁃2930. doi: 10.1016/j.jaip.2021.02.049.
|
| ［4］ |
Muñoz⁃Bellido FJ, Moreno E, Dávila I. Dupilumab: a review of present indications and off⁃label uses［J］. J Investig Allergol Clin Immunol, 2022,32（2）:97⁃115. doi: 10.18176/jiaci.0682.
|
| ［5］ |
Huang HY, Yang CY, Yao WT, et al. Kimura disease of the thigh treated with surgical excision and dupilumab［J］. Ann Plast Surg, 2022,88（1s Suppl 1）:S110⁃S113. doi: 10.1097/SAP.00000 00000003106.
|
| ［6］ |
Teraki Y, Terao A. Treatment of Kimura disease with dupilumab［J］. JAMA Dermatol, 2022,158（3）:329⁃330. doi: 10.1001/jamadermatol.2021.5885.
|
| ［7］ |
Bellinato F, Mastrosimini MG, Querzoli G, et al. Dupilumab for recalcitrant Kimura disease［J］. Dermatol Ther, 2022,35（9）:e15674. doi: 10.1111/dth.15674.
|
